Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
The Hackett Group (NASDAQ:HCKT) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.34 by 8.82 percent. This is a 15.62 percent increase over earnings of $0.32 per share from
The Hackett Group (NASDAQ:HCKT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
The Hackett Group (NASDAQ:HCKT) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
The Hackett Group beat estimated earnings by 18.75%, reporting an EPS of $0.38 versus an estimate of $0.32.